Showing results (51-60 of 167) with videos related to
Sort By:
Pageof 17
Brain : a Journal of Neurology|June 6, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel diseaseSarah McGlasson, Katy Reid, Anna Klingseisen, et al.Australian and New Zealand Journal of Public Health|January 16, 2004
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) studyDianna Magliano, Danny Liew, Helen Pater, et al.BMC Medical Research Methodology|April 2, 2010
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID studyJisheng Cui, Andrew Forbes, Adrienne Kirby, et al.Journal of Patient Safety|December 2, 2011
The chasing zero department: making idealized design a realityCharles R Denham, Peter Angood, Don Berwick, et al.Journal of Patient Safety|December 2, 2011
Chasing zero: can reality meet the rhetoric?Charles R Denham, Peter Angood, Don Berwick, et al.Frontiers in Pediatrics|June 8, 2017
Unexpected Findings in a Child with Atypical Hemolytic Uremic Syndrome: An Example of How Genomics Is Changing the Clinical Diagnostic ParadigmEleanor G Seaby, Rodney D Gilbert, Gaia Andreoletti, et al.Respiratory Medicine|May 22, 2007
Lessons learned from handling a large rural outbreak of Legionnaires' disease: Hereford, UK 2003David Kirrage, David Hunt, Sue Ibbotson, et al.Healthcare (Basel, Switzerland)|December 22, 2023
A Panel-Agnostic Strategy 'HiPPo' Improves Diagnostic Efficiency in the UK Genomic Medicine ServiceEleanor G Seaby, N Simon Thomas, David Hunt, et al.European Heart Journal|May 4, 2004
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID studyDavid Colquhoun, Anthony Keech, David Hunt, et al.Plos One|May 27, 2020
Systematic review of prediction models in relapsing remitting multiple sclerosisFraser S Brown, Stella A Glasmacher, Patrick K A Kearns, et al.Pageof 17